Delivery Order SPE2DB22D3019-SPE2DB25FK4FM
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Clomid 50 mg tablets (30-count) with a ceiling value of $4,422.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside provision was utilized for this procurement. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $3,506.24. This competitive delivery order, which employs firm fixed price contracting, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 tablets. This competitively awarded, non-set-aside contract carries a ceiling value of $9,458.24 under firm fixed price terms, with an ultimate completion date of July 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count packages). This competitively awarded contract, with no set-aside designation, carries a ceiling value of $3,474.31 and has a completion date of June 4, 2025. The contract represents a firm fixed price delivery order, reflecting standard pharmaceutical procurement practices for federal medical supply needs. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units, with a contract ceiling value of $2,108.22 and a completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the vendor's critical role in supporting federal pharmaceutical supply chains. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.70 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count), with a ceiling value of $7,314.66. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.18 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 10s. This competitively awarded, non-set-aside contract was finalized on April 22, 2025, with an ultimate completion date of April 23, 2025, and represents a firm fixed-price delivery order. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,474.96. This competitively awarded, non-set-aside contract has a firm fixed price structure and an ultimate completion date of August 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4FMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clomid 50 mg tablets in unit-dose packaging (30-count) under a firm fixed-price arrangement. The contract has a ceiling value of $4,717.22 and is scheduled for completion by September 15, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen fulfills pharmaceutical procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including brand-name and generic medications, across multiple therapeutic domains to support military and veteran healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/12/25 |